Pendulum, a research-based health company, has launched a groundbreaking new product - a probiotic supplement designed to naturally suppress appetite
Clinical trials show dose-dependent efficacy: 10 mg achieves approximately 19% weight loss, 15 mg approximately 21% weight loss in the SURMOUNT trials
For researchers serious about long-term metabolic optimization, having a comprehensive resource prevents the gaps in care that derail progress
Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalised type 2 diabetes care a systematic review and network meta-analysis
In fact, in a recent study published in The New England Journal of Medicine, participants who took Semaglutide lost an average of 15% of their body weight over a period of 68 weeks
Your doctor may recommend staying at the current dose longer before escalating, using supportive medications for symptom management, or determining if Zepbound is appropriate for you